Profile
ACIU NVO VRTX REGN MRNA SGEN
Company Name AC Immune SA Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $229.15M $564.36B $109.10B $105.53B $44.96B $43.15B
Employees 0.13K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Dr. Andrea Pfeifer Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ACIU NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 5 5 5 2 3
Quant Rating Sell Strong Buy Strong Buy Strong Buy Sell Neutral
Trading
ACIU NVO VRTX REGN MRNA SGEN
Last Close $2.31 $128.42 $422.78 $973.8 $117.31 $228.74
High 52 $5 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $1.9 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High -53.8 % -35.64 % -5.22 % -1.97 % -14.84 % -0.07 %
Price vs. 52 Week Low 21.58 % 46.3 % 30.66 % 40.63 % 68.77 % 21.9 %
Total Return
ACIU NVO VRTX REGN MRNA SGEN
1 Month Return -15.69 % 3.14 % 6.61 % 7.64 % 11.58 % 0 %
3 Month Return -20.34 % 6.55 % 1.02 % 2.82 % 31.81 % 0 %
6 Month Return -20.34 % 26.91 % 13.15 % 21.89 % 67.47 % 7.03 %
9 Month Return -24.26 % -29.28 % 20.84 % 20.68 % 15.59 % 17.5 %
YTD Return -53.8 % 24.14 % 3.91 % 10.87 % 17.96 % 0 %
1 Year Return 10.53 % -25.02 % 21.69 % 30.83 % -9.27 % 14.94 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -75.42 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ACIU NVO VRTX REGN MRNA SGEN
Asset Growth -1.68 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth 29.43 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth 276.14 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year -18.57 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year 50.22 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year -68.02 % 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth 24.31 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth 23.35 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share 25.87 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 22.28 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -430.16 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth 24.31 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) 17.89 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG 13.84 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG -0.06 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -124.19 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth 24.71 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth 24.71 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -6.22 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -36.71 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -33.97 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 347.74 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 24.85 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth 18.18 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ACIU NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM -268.93 % 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -29.67 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -37.49 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -31.69 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 100.02 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 101.12 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -362.3 % 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -1727.42 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM 0.94 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 32.52 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM -87.79 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM 215.01 % 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 8.1 % 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -0.7 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -0.71 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 118.8 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -408.13 % 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.33 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -1727.42 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -3.39 77.7 31.36 26.55 -12.24 -61.54
Price To Operating Cash Flows Ratio TTM -3 42.47 27.68 22.15 -15.55 -79.67
Price Cash Flow Ratio TTM -3 42.47 27.68 22.15 -15.55 -79.67
Income Statement (TTM)
ACIU NVO VRTX REGN MRNA SGEN
Revenue $0.01B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0.04B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio -268.93% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.05B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -0.64 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ACIU NVO VRTX REGN MRNA SGEN
Long Term Debt $0B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.02B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.16B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.02B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.18B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ACIU NVO VRTX REGN MRNA SGEN
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.78
ABCL AbCellera Biologics Inc. 3.83
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 3.47
ABOS Acumen Pharmaceuticals, Inc. 3.36
ABSI Absci Corporation 4.91
ABUS Arbutus Biopharma Corporation 2.88
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 14.09
ACAD ACADIA Pharmaceuticals Inc. 15.25
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.47
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9401
ACHV Achieve Life Sciences, Inc. 4.61
ACLX Arcellx, Inc. 49.74
ACRV Acrivon Therapeutics, Inc. Common Stock 8.77
ACST Acasti Pharma Inc. 2.76
ACXP Acurx Pharmaceuticals, Inc. 2.03
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01369 133.4
GWX SPDR S&P International Small Cap ETF 0.02 32.31
BIB ProShares Ultra Nasdaq Biotechnology 0.00740544 54.47
BMED BlackRock Future Health ETF 0.09076 25.0141
IBBQ Invesco Nasdaq Biotechnology ETF 0.024 21.69
DFAC Dimensional U.S. Core Equity 2 ETF 0 31.62
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0257 5.828
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0244 6.2875
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02457 6.308
Unlock